Koninklijke Philips NV vs Prologis Inc — how do they compare? Koninklijke Philips NV trades at $24.22 (market cap $23.52B), while Prologis Inc trades at $129.53 (market cap $122.87B). The key difference: Prologis Inc is far larger — about 5.2× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Prologis Inc for 102 Days on average.
| PHG | PLD | |
|---|---|---|
Market Cap | $23.52B | $122.87B |
Volume | 1,635,069 | 4,222,957 |
Sector | Health | Real Estate |
52-Week High | $32.91 | $149.96 |
52-Week Low | $23.81 | $111.23 |
Typical Hold Time | 84 Days | 102 Days |
Enterprise Value | $29.87B | $157.61B |
Dividend Yield | 4.17% | 3.31% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.225, up 0.56% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent news highlights Philips' innovation in healthcare technology including new product launches and strategic partnerships.
While valuation appears reasonable with P/E of 18.94 and EV/EBITDA of 8.86, the stock faces headwinds from bearish technical indicators and mixed analyst sentiment. Investment opportunity lies in continued earnings momentum and healthcare technology leadership, balanced against competitive pressures and execution risks in a challenging market environment.
Prologis (PLD) trades at $129.18, up 1.48% today, with a bearish technical signal but strong fundamentals. The stock faces near-term resistance at $130, with support at $127. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $1.13 versus $0.747 expected. Revenue grew to $8.79B in 2025, and net income margin remains robust at 45.79%. The company benefits from strong warehouse demand driven by e-commerce and data centers, as highlighted in recent news.
Outlook is positive with a consensus price target of $155.15, implying 20% upside, supported by 59.5% analyst buy ratings. Risks include rising debt-to-asset ratio (37.2% in 2025) and macroeconomic sensitivity. Institutional interest is strong, with QRG Capital increasing holdings by 11% in Q2 2026. The dividend yield of approximately 0.83% adds income appeal, but investors should monitor leverage and interest rate impacts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →